Health•Two Humanoid Robots Removed an Organ From a Living Animal, but They Were Not Acting AloneHumanoid robots have completed gallbladder surgery on live pigs for the first time. The milestone could reshape access to surgery, but every movement was still controlled by human surgeons.
Health•A Brain Implant Let a Man With ALS Speak and Work Independently for 3,800 HoursA man with severe paralysis caused by ALS used an implanted brain–computer interface independently at home for more than 3,800 hours over 19 months. The system decoded nearly two million attempted words and enabled speech, messaging, web browsing and full-time work—but it remains an invasive, wired research device tested in only one participant.
Health•KAUST’s 6.7-Gram Microneedle Patch Tracks Drug Levels in Real TimeKAUST researchers built a 6.7-gram wearable patch that samples interstitial fluid, measures vancomycin concentrations and transmits readings to a smartphone. The preclinical prototype could eventually complement periodic blood tests, but it still needs longer-duration testing and clinical validation.
Health•A Single LSD-Derived Dose Shows Phase 3 Promise Against Major DepressionDefinium Therapeutics reported that a single dose of DT120 significantly reduced major-depression symptoms six weeks after treatment in a Phase 3 trial. The findings could advance psychedelic medicine toward regulatory review, but full peer-reviewed data, long-term safety and independent confirmation remain essential.
Health•Personalized mRNA Cancer Vaccines Move Closer to Long-Term Clinical UseFive-year melanoma data and a growing wave of clinical studies are strengthening the case for personalized mRNA cancer vaccines. Unlike preventive vaccines, these treatments are built from each patient’s tumor mutations and are designed to train the immune system after cancer has appeared.
Health•Daraxonrasib Signals a Potential Turning Point in Pancreatic CancerAn experimental RAS-targeted therapy more than doubled median overall survival against standard chemotherapy in a closely watched pancreatic-cancer study. Broader confirmation and regulatory review remain necessary.
